Introduction {#sec1}
============

Cell-to-cell competition among male germline stem cells has been proposed to account for the higher frequency of some disorders among children of older fathers, a correlation referred to as the paternal age effect (PAE) ([@bib8]). In addition to compelling observations in humans, evidence of male germline selection was noted in early mammalian models of genetic mosaicism ([@bib11]). However, the mechanism of positive selection for PAE mutations has not been directly interrogated in an experimental stem cell model.

Consistent with a role of germline selection, landmark studies correlated increasing numbers of pathogenic alleles with men's age either in sperm or in microanatomical clusters in the normal testis ([@bib3; @bib9]). The observed rise in mutant allele frequency was above that which could be explained by alternate hypotheses (e.g., mutational hot spots) and was attributed to positive selection of mutant spermatogonial stem cells (SSCs), which represent the only long-lived germ cell in the mammalian testis. This provocative concept has been referred to as the selfish selection hypothesis ([@bib8]).

Several factors are crucial for SSC maintenance in mammals. Among these, glial cell line-derived neurotrophic factor (GDNF), secreted by Sertoli cells, binds to the RET/GFRα1 receptor complex, providing a critical signal for SSC survival ([@bib19]). Seminal studies that established SSC culture conditions identified additional niche-derived growth factors (e.g., fibroblast growth factor \[FGF\] and epidermal growth factor \[EGF\]) that support maintenance of SSCs in vitro ([@bib14]). While genetic models determined that GDNF is essential, the effects of other growth factors in SSC fate decisions remain largely unclear.

Several signaling pathways and unique transcriptional programs are thought to control SSC self-renewal and differentiation in mammals. Transcriptional regulators typically associated with SSC self-renewal include *Plzf*, *Etv5*, *Bcl6b*, *Pou3f1*, *Lhx1*, and *Foxo1* ([@bib2; @bib5; @bib7]). GDNF induces *Etv5*, *Bcl6b*, and *Pou3f1* ([@bib20]). Etv5 and Foxo1 induce *Ret* expression, establishing a positive feedback mechanism for GDNF signaling to maintain self-renewal. FGF2 also increases the expression of *Etv5* through mitogen-activated protein kinase (MAPK) activation, contributing to SSC self-renewal, at least in part by increasing GDNF/RET signaling ([@bib10]). Additionally, activation of the AKT and MAPK signaling pathways by GDNF and FGF2 were correlated with SSC maintenance ([@bib15]).

While SSC self-renewal requires growth factor signaling, previous studies have found that stem cell activity is impaired in the presence of excess FGF- or EGF-mediated signaling ([@bib14]). Moreover, excessive self-renewal signals induce oncogenic transformation and impair SSC maintenance ([@bib7; @bib16]). In contrast, gain-of-function (GOF) mutations in fibroblast growth factor receptor 2 (FGFR2), associated with enhanced FGF signaling, are the basis for Apert syndrome, in which the PAE is particularly robust ([@bib3]). Furthermore, other disorders that exhibit a strong PAE (e.g., achondroplasia and MEN2B) are due to mutant alleles that also increase growth factor signaling in affected organs and tissues ([@bib8]). Hence, the selfish spermatogonial selection hypothesis presents a conundrum, since balanced signaling (i.e., through AKT and MAPK) seems necessary for SSC maintenance ([@bib12]). The aim of this study is to provide direct experimental evidence for the PAE mechanism in Apert syndrome and to reconcile how activating mutations could improve stem cell fitness. To this end, we constructed a model system with adult mouse SSCs. Both in long-term culture and upon transplantation into recipient mice, we demonstrate that a human Apert syndrome allele confers enhanced fitness to SSCs, concomitant with increased downstream signals that support self-renewal of SSCs.

Results {#sec2}
=======

Expression of FGFR2 in Human Testis and Adult Mouse SSCs {#sec2.1}
--------------------------------------------------------

FGFR2 mutations (e.g., S252W) in Apert syndrome accumulate in the testes of older men ([@bib9]). However, previous studies did not establish FGFR2 protein distribution in spermatogonia. When we attempted to localize FGFR2 using conventional immunostaining, no signal was observed (data not shown). Then, by using the highly sensitive tyramide signal amplification (TSA) approach, anti-FGFR2 monoclonal immunoreactivity was detected adjacent to the basement membrane in the human testis, consistent with the known location of spermatogonia. No reactivity was observed in differentiated germ cells or Sertoli cells ([Figure 1](#fig1){ref-type="fig"}A). We next evaluated the expression of FGFR2 in the human testis by quantitative RT-PCR (qRT-PCR). FGFR2 was detected at the mRNA level in samples of normal adult human testis across a wide age range (17--62 years; [Figure 1](#fig1){ref-type="fig"}B).

To confirm that mouse SSCs represent a good model in which to address the PAE mechanism in Apert syndrome, SSCs in long-term culture were tested for FGFR2 expression. We had previously derived primary SSC lines from adult mice and confirmed their stem cell activity in vivo ([@bib17; @bib23]). Expression of FGFR2 was found by both qRT-PCR and immunofluorescence (IF) with TSA in several independently derived SSC lines ([Figures 1](#fig1){ref-type="fig"}C and 1D). Taken together, these data suggest that FGFR2 is normally expressed in the mammalian testis, albeit at low levels, in cell populations that could propagate a long-term clonal effect. Based on this, we used mouse SSC lines to address the cellular mechanism of the FGFR2-mediated PAE.

Ectopic Expression of hFGFR2 Alleles in Mouse SSCs {#sec2.2}
--------------------------------------------------

To test the selfish selection hypothesis experimentally and assess fitness of wild-type (WT) versus mutant SSCs, we generated adult mouse SSCs stably expressing WT human FGFR2 or the PAE-associated FGFR2 S252W Apert syndrome mutation (referred to as WT or S252W hFGFR2 hereafter) by transduction with lentiviruses. Expression levels of hFGFR2 in each SSC line were measured by qRT-PCR with specific primers for the human gene ([Figures 2](#fig2){ref-type="fig"}A and 2B). Human FGFR2 protein expression in SSCs was compared by IF and immunoprecipitation followed by immunoblot (IB) with monoclonal antibodies that specifically recognize hFGFR2, confirming similar expression levels for both hFGFR2 alleles and equivalent cellular distribution ([Figures 2](#fig2){ref-type="fig"}C and 2D).

Potential mechanisms that would result in a selective advantage to different clonal cell populations within a given environment include enhanced proliferative capacity or survival. We compared each of these parameters in WT and S252W SSCs by measuring expansion of cell populations over time, mitotic fraction, apoptosis, and also cell adhesion. No significant differences were found between the two cell populations ([Figures S1](#app2){ref-type="sec"}A--S1D available online). Next, we asked whether alterations in the frequency of asymmetric (*i.e*., differentiating) cell divisions could change the ratio of WT versus mutant spermatogonia. As a surrogate for differentiation capacity, we tested the response of WT and mutant SSCs to retinoic acid (RA), shown previously to initiate spermatogonial differentiation in vitro in a physiologically relevant manner ([@bib6]). Both cell populations responded appropriately to RA exposure by upregulating genes associated with differentiation and downregulating stem cell-associated genes ([Figure S1](#app2){ref-type="sec"}E). To determine whether the stem cell phenotype per se could mediate the PAE observed in Apert syndrome, we surveyed expression levels of genes associated with self-renewal and differentiation in WT versus S252W SSCs ([Figures S1](#app2){ref-type="sec"}F--S1H). Although consistent differences in expression of most genes were not seen, we did find markedly higher expression of *Etv5*, a critical transcription factor for SSC maintenance, in S252W SSCs ([@bib20]).

S252W SSCs Exhibit Enhanced Sensitivity to Growth Factors {#sec2.3}
---------------------------------------------------------

Our preliminary characterization of the hFGFR2 SSC lines suggested a mechanism of autonomously increased self-renewal potential of S252W SSCs. However, relatively little is known about how FGFR2-mediated signaling affects SSC self-renewal. Previous studies in other cellular contexts have demonstrated that the S252W FGFR2 mutant receptor exhibits decreased ligand dissociation ([@bib1]). Accordingly, we compared pMAPK and also pAKT levels in WT and S252W SSCs upon FGF2 stimulation. While no consistent differences were detected at ≥0.5 ng/ml FGF2 (data not shown), S252W SSCs yielded greater pMAPK and, to a more moderate extent, greater pAKT at lower FGF2 concentrations than WT cells ([Figures 3](#fig3){ref-type="fig"}A and [S2](#app2){ref-type="sec"}A). Notably, in the presence of reduced FGF2 (1 ng/ml), there was no difference in the proliferation of the two cell variants ([Figure 3](#fig3){ref-type="fig"}B).

Based on our observations with hFGFR2 SSCs, we interrogated the effect of FGF dose on downstream signaling through endogenous FGF receptors. Low doses of FGF2 induced pMAPK and pAKT and loss of pStat3 ([Figures S2](#app2){ref-type="sec"}B--S2D). However, higher doses of FGF2 reversed this effect. In contrast, GDNF induced a dose-dependent increase in pMAPK and pAKT ([Figures S2](#app2){ref-type="sec"}E and S2F). To test the sustained effects FGF2, we profiled SSCs at varying chronic doses (0--10 ng/ml) and found an inverse relationship of FGF dose and expression levels for certain stem cell markers (*i.e*., *Id4*, *Etv5*, and *Sall4*), while other markers (*Ret*, *Pou3F1*, *Lhx1*, and *Kit*) did not change ([Figures S2](#app2){ref-type="sec"}G and S2I). These data are generally concordant with a previous study using a different culture system, which showed that SSCs maintained at a relatively low FGF2 dose exhibit higher colonization activity, compared to SSCs cultured with higher doses of FGF2 ([@bib14]).

Based on the increased responsiveness of S252W SSCs to FGF ([Figures 3](#fig3){ref-type="fig"}A and [S2](#app2){ref-type="sec"}A), we asked next whether enhanced FGFR2 signaling could alleviate the requirement for GDNF. To test this possibility, WT and S252W SSCs were cultured in reduced FGF2 and GDNF concentrations. Compared to WT SSCs, S252W SSCs exhibited increased cell recovery under these conditions and were able to overcome a substandard GDNF concentration ([Figure 3](#fig3){ref-type="fig"}C). Collectively, these results suggest that the Apert S252W mutation enables SSCs to withstand the potentially detrimental effects of reduced growth factors in the niche.

Competition between WT and S252W SSCs {#sec2.4}
-------------------------------------

Our data above suggest an increased self-renewal capability of S252W SSCs, particularly when growth factors are limited. However, the selfish selection hypothesis proposes a competition-based mechanism ([@bib8]). Thus, we asked next whether the Apert S252W mutation confers higher functional stem cell activity and a selective advantage that enables mutants to outcompete WT counterparts. To this end, differentially labeled WT and S252W SSCs expressing GFP or mCherry, respectively, were cocultured in vitro for several weeks or mixed immediately prior transplantation as shown in [Figure 4](#fig4){ref-type="fig"}A.

For in vitro evaluation, differentially labeled populations were mixed in the presence of varying FGF concentrations to impose a selective pressure. Changes in the S252W-to-WT ratio were measured serially by flow cytometry (fluorescence-activated cell sorting \[FACS\]; [Figures 4](#fig4){ref-type="fig"}B and [S3](#app2){ref-type="sec"}C, and S3D). After several weeks of coculture, S252W-expressing SSCs progressively outcompeted WT cells independently of the initial mixing ratio and became the predominant population in the culture. Of note, this difference was only observed in the presence of reduced FGF conditions, but not in standard culture media ([Figures 4](#fig4){ref-type="fig"}B and [S3](#app2){ref-type="sec"}A).

We next assessed stem cell activity of cultured WT and S252W SSCs in vivo by transplantation into busulfan-treated mice. Differentially labeled WT and S252W SSCs were mixed immediately prior to transplantation into the testis. GFP^+^ and mCherry^+^ colonies were counted 2 months after surgery, revealing that mutant cells exhibited significantly greater stem cell activity than WT ([Figure 4](#fig4){ref-type="fig"}C). Similar results were obtained when GFP and mCherry labels were reversed, excluding intrinsic effects of the labeling system. In an alternate experimental design, the two populations were mixed and cocultured in vitro for several weeks prior to transplantation with similar results (data not shown). Collectively, these data demonstrate that the S252W PAE mutation confers a fitness advantage to SSCs.

Discussion {#sec3}
==========

The selfish spermatogonia selection hypothesis proposes that pathogenic alleles in human PAE disorders become enriched through clonal expansion of mutant SSCs that possess an acquired competitive advantage ([@bib8]). Here, we modeled stem cell fitness prospectively to address the effects of a PAE-associated hFGFR2 mutation in adult SSCs. In vitro cell competition data together with cotransplantation constitute the only experimental evidence to date for increased fitness and stem cell activity of mutant S252W SSCs over WT.

Cell competition in adults plays a role in organ homeostasis; for example, germline stem cells in *Drosophila* continuously compete for niche occupancy ([@bib26]). To some extent, stem cell replacement occurs in a stochastic manner ([@bib13]). However, sporadically occurring mutations during aging or certain pathological processes (e.g., cancer) can influence stem cell dynamics. The competitive advantage of tumor cell subclones provides a compelling analogy for the PAE mechanism proposed here and elsewhere ([@bib8]). Even so, several features differ. First, tumor cells do not retain their full differentiation capacity or functionality as differentiated cells. Our data show that mutant SSCs are capable of responding to RA similar to WT cells in vitro, suggesting that early differentiation is unaffected. Also, our studies did not detect marked differences in FGF-mediated proliferation or survival of SSCs in vitro, even under media conditions in which a competitive advantage was observable. On the other hand, mutant cells exhibit increased expression of *Etv5*, a critical transcription factor to maintain SSCs, implying some level of intrinsically elevated self-renewal capability of mutant cells over WT.

Also intriguing is the minimal overlap between the spectrum of acquired mutations in the most common forms of testicular cancer and the congenital variants observed in PAE disorders. In addition to Apert syndrome alleles, other pathogenic mutations, including those in RET and PTPN11, exhibit both a strong PAE and evidence of clonal expansion of SSCs ([@bib25]). However, most PAE mutations documented to date are weakly acting, consistent with the idea that excessive upstream signal is deleterious to self-renewal. Indeed, we found diminished pMAPK and pAKT but increased pSTAT3 when SSCs were exposed to high FGF2. This finding also fits with the decreased SSC colonization observed when SSC are cultured in higher FGF or EGF doses ([@bib14]). Accordingly, S252W SSCs exhibited increased sensitivity to low FGF2 doses, as evidenced by slightly enhanced downstream signaling (i.e., through MAPK and AKT), compared to WT SSCs. Taken together, these data could provide a further explanation for why only mild GOF mutations are typically found in congenital disorders, as opposed to strongly activating somatic mutations in tumorigenesis.

Enhanced downstream signaling could confer resistance to a suboptimal niche. Strikingly, a recent study in a model of intestinal tumorigenesis showed that stem cells bearing activating mutations only acquired an advantage in a deteriorated niche ([@bib24]). In fact, we observed an in vitro advantage for mutants in low FGF2 conditions only. However, the finding that mutant SSCs grown in standard, high growth factor media still exhibited higher stem cell activity at transplant suggests that the FACS-based metric of fitness in vitro may be less sensitive than the transplant-based readout. Also, it is certain that the culture milieu does not perfectly recapitulate the stem cell niche in vivo. Unexpectedly, our data also show that mutant SSCs can be maintained even when GDNF is limiting. Finally, previous studies revealed decreased expression of critical SSC growth factors, such as GDNF and FGF2, during normal aging and an age-related decline in niche function ([@bib21]). Taken together, these findings suggest that niche-dependent signaling in the mammalian testis must undergo exquisite regulation to avoid stem cell loss. Therefore, slight changes in the microenvironment could have profound effects on cell phenotype, such that otherwise neutral genotypes become beneficial under stressful conditions or with aging.

Other cell-extrinsic mechanisms may lead to a progressive loss of WT cells through an active process that eliminates the least fit populations. Such processes occur during normal development in the mammalian embryo, in which relatively unfit populations are deleted through apoptosis ([@bib4]). At present, we cannot exclude the possibility that active elimination of WT cells contributes to selection of FGFR2 S252W mutants. Perhaps the degree of PAE observed in different disorders reflects diverse mechanisms of stem cell competition occurring in the testis.

While the association between paternal age and risk monogenic disorders was observed \>100 years ago, a variety of recent evidence has implicated de novo mutations in complex disorders, such as autism and schizophrenia ([@bib8]). We speculate that a subset of such mutations become enriched by a similar mechanism as in Apert syndrome. Therefore, in a society of increasingly older fathers, a relatively large swath of disease risk could originate in SSCs, even if the absolute increase in risk due to paternal age for any one disorder is low ([@bib18]). For these reasons, it will be essential to more thoroughly elucidate the common mechanisms (or divergent pathways) that lead to SSC competition in subsequent studies.

Experimental Procedures {#sec4}
=======================

SSC Culture {#sec4.1}
-----------

SSC lines were derived from C57Bl6/129S adult mice and maintained on mitotically inactivated JK1 feeder cells as previously described ([@bib17]). StemPro-34 containing 20 ng/ml GDNF, 10 ng/ml FGF2, 20 ng/ml EGF, and 25 μg/ml insulin was used for SSC culture ([@bib23]). SSC lines stably expressing hFGFR2 alleles and GFP or mCherry were generated by lentivirus. Feeder-free SSCs were treated with 1 μM RA or vehicle control for 72 hr ([@bib6]). For cytokine stimulation, feeder-free SSCs were starved overnight and stimulated for 20 min with growth factors. Experiments were performed at least twice using SSC lines derived from different mice. For in vitro competition, mixed, differentially labeled WT and S252W SSCs were plated in triplicate and cocultured for several weeks in FGF2 (0.2--10 ng/ml). The mutant-to-WT ratio was determined serially by FACS (Accuri C6). All mouse experiments were performed in accordance with institutional and national guidelines and regulations including the Weill Cornell Medical College Institutional Animal Care and Use Committee.

SSC Transplantation {#sec4.2}
-------------------

SSC transplant assays were performed as described previously using busulfan-conditioned mice ([@bib23]). Differentially labeled WT and S252W SSCs were mixed immediately prior to transplantation or first cocultured in vitro for several weeks. Two months later, detunicated recipient testes were analyzed for GFP^+^ or mCherry^+^ colonies and quantified using a fluorescent stereoscope (Zeiss).

Immunodetection {#sec4.3}
---------------

Human cadaver testis tissue was obtained from the New York Organ Donor Network ([@bib22]). Whereas IHC for endogenous FGFR2 in human tissue and SSC lines required TSA, detection of ectopic human FGFR2 was performed using standard biotin-conjugated secondary antibodies and streptavidin-fluorophore conjugates as detailed in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}. FGFR2 was detected using two different monoclonal anti-human FGFR2 antibodies (ab119237, Abcam; and sc-6930, Santa Cruz Biotechnology). Phospho-histone 3 serine10 (PH3) was detected with anti-PH3 (Millipore 06-570). Immunoprecipitation was performed using protein lysates from feeder-free SSCs and anti-human FGFR2 rabbit monoclonal antibody (D4H9, Cell Signaling). Immunoblot was performed with anti-human FGFR2 antibody (ab119237, Abcam). Detailed methods are found in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

For more information, please refer to [Supplemental Experimental Procedures](#app2){ref-type="sec"}.
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![Expression of FGFR2 in Human Testis and in Mouse SSCs\
(A) IHC with tyramide signal amplification (TSA) on adult human testis, showing positive reactivity (reddish brown; arrows) to monoclonal anti-human FGFR2 antibody exclusively in spermatogonia along the basement membrane (inset, mouse IgG; scale bar, 100 μm).\
(B) qRT-PCR showing *FGFR2* expression levels in human testis from young (17--25 years; mean ± SD, n = 3 donors) and older (49--62 years; mean ± SD, n = 5 donors) cohorts.\
(C) Relative *Fgfr2* expression in SSC lines compared to mouse testis (mTestis) using primers annealing in the extracellular (ECD) and the kinase domains, respectively (mean ± SD; n = 3 biological replicates).\
(D) Immunostaining with TSA (green) in cultured mouse SSC cytospin preparations showing endogenous FGFR2 protein expression with two different monoclonal antibodies (moAb) (scale bar, 25 μm).](gr1){#fig1}

![Delivery of Ectopic Human FGFR2 Alleles in Adult Mouse SSCs\
(A) Schematic of FGFR2 protein and primers for human-specific *FGFR2* qRT-PCR. Asterisk marks the location of the S252W Apert mutation (ECD, extracellular domain).\
(B) qRT-PCR using two sets of primers showing relative expression levels of hFGFR2 in lentivirus-transduced SSCs bearing WT hFGFR2 (WT) or human S252W FGFR2 (S252W) with untransduced SSCs as the reference control (mean ± SD of three independent cell lines per genotype).\
(C) IF on cytospins (top row) with anti-hFGFR2 antibody (green) for SSCs stably expressing WT (middle) or S252W (right) alleles and untransduced SSCs as control (left). Scale bar, 10 μm. Phase contrast (bottom row) of untransduced SSCs (control; left) or stably expressing hFGFR2 WT (middle) or S252W (right) alleles in standard culture conditions (scale bar, 50 μm).\
(D) Immunoprecipitation (IP) and detection with two specific monoclonal antibodies for hFGFR2 in WT and S252W SSC. Controls: untransduced SSCs and JK1 feeder cells or 293T cells transduced with WT or S252W lentiviruses. Grey dashed line denotes cropped lane.\
See also [Figure S1](#app2){ref-type="sec"}.](gr2){#fig2}

![Enhanced Sensitivity of S252W SSCs to FGF\
(A) Representative anti-p42/44 MAPK (pErk1/2) IB in WT and S252W SSCs in response to FGF2 doses (0.05 and 0.25 ng/ml). Grey dashed line denotes cropped lane. Graphs correspond to densitometric analyses of IB image above for pErk1/2, normalized to loading control (GADPH), with values shown for each condition in arbitrary units (A.U.).\
(B and C) Proliferation curves showing WT and S252W SSC numbers (mean ± SD; n = 3 wells/condition) after 2--4 weeks in vitro with either (B) reduced FGF2 (1 ng/ml) or (C) reduced GDNF (doses shown) and reduced FGF2 (1 ng/ml). Curves correspond to two biological replicates. Bar graph in (B) depicts fold change in total cell number of S252W versus WT SSCs at indicated time points in three biological replicates (mean ± SD).\
See also [Figure S2](#app2){ref-type="sec"}.](gr3){#fig3}

![Enhanced Stem Cell Fitness of S252W SSCs\
(A) Schematic of mixing experiments to assess fitness of WT versus S252W SSCs. For in vitro experiments, differentially labeled WT and mutant SSCs were mixed and cultured with different doses of FGF2. Stem cell activity was measured by transplantation into busulfan-treated mice. Two months after transplantation, the number of GFP and mCherry colonies in each testis was counted.\
(B) In vitro mixing experiment showing a significant change over time in the ratio (FACS) of cocultured S252W and WT SSCs in reduced FGF2 (1 ng/ml), for both 1:1 and 1:2 starting ratios. Curves correspond to one representative biological replicate and show the mean (±SD; n = 3 wells/time point). Fluorescent images show mixed SSC colonies (scale bar, 50 μm). Bar graphs show the starting (i.e., measured postplating) and final ratios in three biological replicates. Error bars correspond to ±SD; n = 3 wells/time point.\
(C) Top: representative transplantation experiment showing colony quantification for each genotype in transplanted testes (n = 14) with mixed WT-GFP and S252W-mCherry SSCs. ^∗∗∗^p \< 0.005 (Wilcoxon matched-pairs signed rank test). Fluorescent images: a transplanted testis with WT (green) and mutant (red) colonies (arrows; dashed line denotes testis border; scale bar, 1 mm) (top image), and representative WT (green) and S252W (red) colony detail (scale bars, 200 μm) (bottom images). Bottom: pooled transplant data (n = 10 experiments, 77 testes) showing the normalized percentage of colonies of each genotype per testis.\
See also [Figure S3](#app2){ref-type="sec"}.](gr4){#fig4}
